Cuban authorities, scientists and health personnel are arranging on Monday the final details for the health intervention study for at-risk groups, with anti-Covid-19 vaccine candidate Abdala, which will begin on Wednesday, in Havana.
The Entrepreneurial Group of the Biotechnological and Pharmaceutical Industries of Cuba (BioCubafarma) stated on Twitter that the doses of Abdala vaccine are ready to be administrated to volunteers in San Miguel del Padron, Habana del Este, Guanabacoa and Regla municipalities, as of Wednesday, May 12.
As Health Minister Jose Angel Portal recently explained, 396,382 inhabitants of those municipalities will receive the doses during the first half of May until June.
Then, 382,016 volunteers from Boyeros, Cotorro and Arroyo Naranjo municipalities will be vaccinated between the last week of May until July.
Between May and June, 474,676 health workers and students nationwide, who were not considered in the intervention study already carried out or in progress, will also receive the vaccine candidate.
Also between May and August, part of the population in Santiago de Cuba, Matanzas, Pinar del Rio provinces and Isla de la Juventud special municipality will be vaccinated, with the vaccine candidates Abdala or Soberana 02, both in Phase III of clinical trials.
Dr. Portal explained that the health intervention study is temporary until the Center for State Control of Medicines, Equipment and Medical Devices (CEDMED), the regulatory authority in Cuba, can issue the authorization for the massive use of these vaccine proposals.